NCT00250939
- Conditions
- Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- Sophia Kinderziekenhuis, Erasmus MC Rotterdam, Netherlands
Clinical trial condition
Metabolism, Inborn Errors
Explore clinical trials studying Metabolism, Inborn Errors. Study availability and eligibility vary by location and protocol.
2,496 public trials
457 recruiting studies
Metabolism, Inborn Errors trial results
Completed
Expanded Access Use of Myozyme (Alglucosidase Alfa) in Patients With Late-onset Pompe Disease
NCT00074932
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- Colorado Health Science Center Aurora, Colorado, United States
- Galichia Heart Hospital Wichita, Kansas, United States
- Genzyme Medical Information Cambridge, Massachusetts, United States
- Freeman Health Systems Joplin, Missouri, United States
NCT00125879
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
- Locations
-
- University of Alabama Birmingham, Alabama, United States
- Shands Hospital at the University of Florida Gainesville, Florida, United States
- Miami Children's Hospital Miami, Florida, United States
- Emory University Medical Genetics Decatur, Georgia, United States
NCT00053573
- Conditions
- Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +15 more
- Locations
-
- University of Florida College of Medicine Gainesville, Florida, United States
- Duke University Medical Center Durham, North Carolina, United States
- Children's Hospital Medical Center Cincinnati, Ohio, United States
- Pediatrique Hopital de Brousse Lyon, France
NCT00763932
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
- Locations
-
- Children's Hospital of Oakland Oakland, California, United States
- Children's Hospital of Orange Country Orange, California, United States
- University of Nebraska Medical Center Omaha, Nebraska, United States
- Institute for Genetic Medicine, Saint Peter's University Hospital New Brunswick, New Jersey, United States
Completed
A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease
NCT00059280
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +12 more
- Locations
-
- University of Florida College of Medicine Gainesville, Florida, United States
- Duke University Medical Center Durham, North Carolina, United States
- Children's Hospital Medical Center Cincinnati, Ohio, United States
- University of Utah Medical Center Salt Lake City, Utah, United States
NCT00051935
- Conditions
- Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +15 more
- Locations
-
- Saint Peter's University Hospital New Brunswick, New Jersey, United States
NCT00268944
- Conditions
- Acid Maltase Deficiency Disease, Brain Diseases, Brain Diseases, Metabolic, +16 more
- Locations
-
- Hopital Raymond Poincare Garches, France
Completed
A Switch-Over Study of the Safety and Efficacy of ISU302 in Patients With Type 1 Gaucher Disease
NCT02053896
- Conditions
- Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +14 more
- Locations
-
Not specified
- Conditions
- Acute Gout, Arthritis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +10 more
- Locations
-
- Novartis Investigative Site Darlinghurst, New South Wales, Australia
- Novartis Investigative Site Fitzroy, Victoria, Australia
- Novartis Investigative Site Heidelberg, Victoria, Australia
- Novartis Investigative Site Daw Park SA, Australia